Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials

MLA

P. Baudin, et al. Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials. Jan. 2016. EBSCOhost, https://doi.org/10.3233/JND-160145.

APA

P. Baudin, Pierre G. Carlier, Paulo Loureiro de Sousa, Benjamin Marty, Eduard Snezhko, Dmitry Vlodavets, & Olivier Scheidegger. (2016). Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials. https://doi.org/10.3233/JND-160145

Chicago

P. Baudin, Pierre G. Carlier, Paulo Loureiro de Sousa, Benjamin Marty, Eduard Snezhko, Dmitry Vlodavets, and Olivier Scheidegger. 2016. “Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials,” January. doi:10.3233/JND-160145.